Pulmatrix, Inc. (PULM) stock
PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.33+0.04 (+3.10%)
Close on Nov 16, 2026Market cap $4.86MP/E –Yield –
Pulmatrix ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Pulmatrix's ebitda for the twelve months ending Dec 31, 2024 was -$9.66M. For fiscal 2024 it was -$9.66M. The highest annual figure on record is -$8.73M in fiscal 2014.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$9.66M | – |
| FY2023 | Dec 31, 2023 | -$14.61M | – |
| FY2022 | Dec 31, 2022 | -$18.79M | – |
| FY2021 | Dec 31, 2021 | -$20.00M | – |
| FY2020 | Dec 31, 2020 | -$9.65M | – |
| FY2019 | Dec 31, 2019 | -$20.51M | – |
| FY2018 | Dec 31, 2018 | -$20.17M | – |
| FY2017 | Dec 31, 2017 | -$17.23M | – |
| FY2016 | Dec 31, 2016 | -$24.62M | – |
| FY2015 | Dec 31, 2015 | -$22.79M | – |
| FY2014 | Dec 31, 2014 | -$8.73M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$1.95M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.66M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.85M | – |
| Q1 FY2024 | Mar 31, 2024 | $806.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.19M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.91M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.96M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.55M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.29M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.06M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.51M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.93M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.01M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.14M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.81M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.03M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.62M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.22M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.12M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.69M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.07M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.63M | – |
| Q2 FY2019 | Jun 30, 2019 | -$7.90M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.91M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.06M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.77M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.07M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.05M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.37M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.25M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.37M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.25M | – |
| Q4 FY2016 | Dec 31, 2016 | -$7.39M | – |
See a number that looks wrong?